CDLX icon

Cardlytics

3.71 USD
+0.16
4.51%
At close Dec 20, 4:00 PM EST
After hours
3.72
+0.01
0.27%
1 day
4.51%
5 days
0.27%
1 month
1.09%
3 months
1.09%
6 months
-54.25%
Year to date
-58.31%
1 year
-56.51%
5 years
-93.94%
10 years
-72.25%
 

About: Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

Employees: 456

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

90% more call options, than puts

Call options by funds: $5M | Put options by funds: $2.64M

19% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 32

11.78% less ownership

Funds ownership: 73.71% [Q2] → 61.93% (-11.78%) [Q3]

13% less funds holding

Funds holding: 127 [Q2] → 111 (-16) [Q3]

38% less funds holding in top 10

Funds holding in top 10: 8 [Q2] → 5 (-3) [Q3]

50% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 32

68% less capital invested

Capital invested by funds: $306M [Q2] → $99.2M (-$207M) [Q3]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$4
8%
upside
Avg. target
$4
8%
upside
High target
$4
8%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
Evercore ISI Group
Mark Mahaney
81% 1-year accuracy
34 / 42 met price target
8%upside
$4
In-Line
Initiated
11 Oct 2024

Financial journalist opinion

Positive
Zacks Investment Research
4 days ago
Here Is Why Bargain Hunters Would Love Fast-paced Mover Cardlytics (CDLX)
Cardlytics (CDLX) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Here Is Why Bargain Hunters Would Love Fast-paced Mover Cardlytics (CDLX)
Neutral
Seeking Alpha
1 month ago
Cardlytics, Inc. (CDLX) Q3 2024 Earnings Call Transcript
Cardlytics, Inc. (CDLX) Q3 2024 Earnings Call Transcript
Cardlytics, Inc. (CDLX) Q3 2024 Earnings Call Transcript
Negative
Zacks Investment Research
1 month ago
Cardlytics (CDLX) Reports Q3 Loss, Tops Revenue Estimates
Cardlytics (CDLX) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to earnings of $0.01 per share a year ago.
Cardlytics (CDLX) Reports Q3 Loss, Tops Revenue Estimates
Neutral
GlobeNewsWire
1 month ago
Cardlytics Announces Third Quarter 2024 Financial Results
ATLANTA, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the third quarter ended September 30, 2024.
Cardlytics Announces Third Quarter 2024 Financial Results
Neutral
GlobeNewsWire
1 month ago
Cardlytics Announces Timing of Its Third Quarter 2024 Earnings Release
ATLANTA, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its financial results for the third quarter ending September 30, 2024 will be released on November 6, 2024, after market close. The results will be discussed via conference call at 5:00 PM ET / 2:00 PM PT.
Cardlytics Announces Timing of Its Third Quarter 2024 Earnings Release
Neutral
Accesswire
2 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
NEW YORK, NY / ACCESSWIRE / September 29, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
Neutral
Accesswire
2 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
Neutral
GlobeNewsWire
2 months ago
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
SAN FRANCISCO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Cardlytics, Inc. (NASDAQ: CDLX) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
Neutral
PRNewsWire
2 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
NEW YORK , Sept. 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX).
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
Neutral
Accesswire
2 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
NEW YORK, NY / ACCESSWIRE / September 23, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
Charts implemented using Lightweight Charts™